This federal contract award, valued at $23,949.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,713,170 units of the drug Ondansetron HCL 4 mg tablets, which are used to treat nausea and vomiting. This is a firm fixed-price delivery order contract with a completion date of December 16, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not include any set-aside designations, indicating open competition.
Generated 3/14/25, 9:47 AM